Dyadic International Inc
Contact Information
Company Details
Location Type: Headquarters
Industry: Biological Products, Except Diagnostic Substances
Ownership: Public
Year Founded: 1979
Sales Range: $1,000,000 to $4,999,999
Employees: 5 to 10
Is This Your Customer, Supplier, Or Partner?
Is This Your Business?
Is This Your Customer, Supplier, Or Partner?
Pull Their Credit Report CREATE A FREE ACCOUNT
Company Credit Alerts
Recent Alerts
Credit Risk Increase
No
Overall Payments
No
Peer Payments
No
Bankruptcy
No
Tax Liens
No
UCC Filings
No
See All Credit Alerts On Your Customers From The Past 12 Months
Company News
Latest News
Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Prote
Feb 28 2024
Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions
Feb 21 2024
Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
Feb 13 2024
Dyadic Appoints Doug Pace to Its Executive Leadership Team
Oct 9 2023
Dyadic Receives U.S. Patent for Manufacturing Seasonal and Pandemic Influenza Vaccines from its Proprietary C1 Protein Production Platform
Apr 18 2023
Analyze Your Entire AR Portfolio with One Free Credit Tool
LEARN MORECompany Buying Behavior
Overall Company Spend
Credit Analysis Tip
Purchases of key products and services provides insight into whether a business is growing or declining financially. Analyzing spending enables creditors predict risk scenarios before other credit analysis methods. Lean how in our latest case study.
DOWNLOAD CASE STUDYCompany Credit Alerts
Recent Alerts
Credit Risk Increase
No
Overall Payments
No
Peer Payments
No
Bankruptcy
No
Tax Liens
No
UCC Filings
No
See All Credit Alerts On Your Customers From The Past 12 Months
Sales Insights
More Businesses Like this
Discover other companies in the same industry you can sell to: